CD Equisearch Pvt Ltd Jun 25, 2019 Equities Derivatives Commodities Distribution of Mutual Funds Distribution of Life Insurance . 21.8x FY18e EPS of Rs Jamna Auto Industries Ltd No. of shares (m) 398.5 Mkt cap (Rs crs/$m) 2124/305.0 Current price (Rs/$) 53/0.8 Price target (Rs/$) 74/1.1 52 W H/L (Rs.) 94/49 Book Value (Rs/$) 12.3/0.2 Beta 1.3 Daily volume NSE (avg. monthly) 358230 P/BV (FY20e/21e) 3.5/2.9 EV/EBITDA (FY20e/21e) 6.7/5.8 P/E (FY20e/21e) 13.3/11.5 EPS growth (FY19/20e/21e) 9.7/16.2/16.0 OPM (FY19/20e/21e) 13.0/12.8/13.0 ROE (FY19/20e/21e) 31.0/29.4/27.8 ROCE(FY19/20e/21e) 32.0/31.1/28.8 D/E ratio (FY19/20e/21e) 0.0/0.0/0.1 BSE Code 520051 NSE Code JAMNAAUTO Bloomberg JMNA IN Reuters JMNA.NS Shareholding pattern % Promoters 47.9 MFs / Banks / FIs 8.3 FPIs 5.0 Govt. Holding 0.0 Public & others 38.8 Total 100.0 As on March 31, 2019 Recommendation BUY Analyst KISHAN GUPTA, CFA, FRM Phone: + 91 (33) 4488 0043 E- mail: [email protected]Consolidated (Rs crs) FY17 FY18 FY19 FY20e FY21e Income from operations 1292.44 1738.12 2134.81 2390.99 2701.82 Other Income 6.09 8.71 10.97 9.93 9.93 EBITDA (other income included) 207.39 246.53 287.67 316.00 361.51 Profit after MI & EO items 104.96 125.34 137.45 159.66 185.22 EPS(Rs) 2.63 3.15 3.45 4.01 4.65 EPS growth (%) 45.3 19.4 9.7 16.2 16.0 Company Brief Jamna Auto manufactures auto suspension products -parabolic/ tapered leaf spring, lift axle and air suspension- mainly for OEMs in the CV segment. Quarterly Highlights • Strangled by no imperceptible slowdown in Indian CV industry, most prominently the stalwart M&HCV - stark change in volumes not invisible as MHCV dispatches tumbled not indiscernibly by 5.5% (yoy) in the second half of last fiscal compared to 48.1% growth in the first half - Jamna's revenue from operations slid 3.4% in the second half of last fiscal. The condition got no better in Q4 as Jamna reported 9% drop in revenues for the first time in seven quarters. • Twin effects of frail volumes and higher raw material prices, suppressed margins not inappreciably - OPMs declined to 12.7% in Q4 compared to 15% in the same period a year ago. Operating profit, as a consequence, nosedived 22.8% to Rs 69.02 crs compared to Rs 89.42 crs in the same period a year ago. Moderation in both interest (down 30.6%) and depreciation expenses (-16.3%) did little to arrest fall in post tax earnings, which fell miraculously by 28.6% on yoy basis. • For full year, bettering overall CV industry sales growth of 17.6%, Jamna reported 22.8% growth in revenue from operations but with marginal dip (~70 bps) in OPMs to 13%. Revenue share of new products (largely parabolic springs) slightly fell to 34% from 37% a year back, while revenue share of new markets increased marginally to 16% from 15% in the year ago period. • After unlocking value in handful of new products namely, parabolic leaf spring, lift axle and air suspension , over the last few years, plans are afoot to launch/ develop new products such as stabilizer bar, U bolt, Z spring and trailer suspension - though meaningful revenue contribution would barely be visible from such products in the medium term. • The stock currently trades at 13.3x FY20e EPS of Rs 4.01 and 11.5x FY20e EPS of Rs 4.65. Most of the growth in earnings over the next two years (16.1% on average) would emerge from not so ebullient volumes but stable margins. Moderation in asset turnover ratios and stress in working capital cycle would barely escape notice. Yet widening net of highly efficient parabolic springs would start to become palpable, providing much needed stability to earnings. Given moderation in stock valuation, we advise buying the stock with revised target of Rs 74 (previous target: Rs 99) based on 16x FY21e earnings (forward peg: 1).
10
Embed
CD Equisearch Pvt Ltd - Markets Mojo...E- mail: [email protected] Consolidated (Rs crs) FY17 FY18 FY19 FY20e FY21e Income fro m operations 1292.44 1738.12 2134.81 2390.99 2701.82
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
CD Equisearch Pvt Ltd Jun 25, 2019
Equities Derivatives Commodities Distribution of Mutual Funds Distribution of Life Insurance
Net fixed assets (incl CWIP) 46.5 51.1 59.6 61.9 68.5
Investments 0.1 0.1 0.1 0.1 0.1
Net current assets -2.9 11.5 6.5 22.4 34.9
Total assets 49.9 64.9 71.1 86.1 105.1
Revenues 192.6 269.7 305.5 343.4 388.0
EBITDA 30.9 38.3 41.2 45.4 51.9
EBDT 28.8 35.3 37.5 42.2 48.7
PBT 21.7 28.9 30.8 34.7 40.3
Profit after MI 15.6 19.4 19.7 22.9 26.6
EPS($) 0.04 0.05 0.05 0.06 0.07
Book value ($) 0.12 0.15 0.18 0.22 0.26
income statement figures translated at average rates; balance sheet and cash flow at year end rates; projections at current rates(Rs 69.63/$). All dollar denominated figures are adjusted for extraordinary items.
10
10
CD Equisearch Pvt Ltd
Equities Derivatives Commodities Distribution of Mutual Funds Distribution of Life Insurance
Disclosure& Disclaimer CD Equisearch Private Limited (hereinafter referred to as ‘CD Equi’) is a Member registered with National Stock Exchange of India Limited,
Bombay Stock Exchange Limited and Metropolitan Stock Exchange of India Limited (Formerly known as MCX Stock Exchange Limited). CD
Equi is also registered as Depository Participant with CDSL and AMFI registered Mutual Fund Advisor. The associates of CD Equi are
engaged in activities relating to NBFC-ND - Financing and Investment, Commodity Broking, Real Estate, etc.
CD Equi is registered under SEBI (Research Analysts) Regulations, 2014 with SEBI Registration no INH300002274. Further, CD Equi hereby
declares that –
• No disciplinary action has been taken against CD Equi by any of the regulatory authorities.
• CD Equi/its associates/research analysts do not have any financial interest/beneficial interest of more than one percent/material
conflict of interest in the subject company(s) (kindly disclose if otherwise).
• CD Equi/its associates/research analysts have not received any compensation from the subject company(s) during the past twelve
months.
• CD Equi/its research analysts has not served as an officer, director or employee of company covered by analysts and has not been
engaged in market making activity of the company covered by analysts.
This document is solely for the personal information of the recipient and must not be singularly used as the basis of any investment decision.
Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such
investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in
this document (including the merits and risks involved) and should consult their own advisors to determine the merits and risks of such an
investment.
Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading
volume, as opposed to focusing on a company's fundamentals and as such, may not match with a report on a company's fundamentals.
The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources
believed to be true but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general
guidance only. CD Equi or any of its affiliates/group companies shall not be in any way responsible for any loss or damage that may arise to
any person from any inadvertent error in the information contained in this report. CD Equi has not independently verified all the information
contained within this document. Accordingly, we cannot testify nor make any representation or warranty, express or implied, to the accuracy,
contents or data contained within this document.
While, CD Equi endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory compliance or
other reasons that prevent us from doing so.
This document is being supplied to you solely for your information and its contents, information or data may not be reproduced, redistributed
or passed on, directly or indirectly. Neither, CD Equi nor its directors, employees or affiliates shall be liable for any loss or damage that may
arise from or in connection with the use of this information.
CD Equisearch Private Limited (CIN: U67120WB1995PTC071521)